DENTSPLY SIRONA (XRAY) Releases FY 2018 Earnings Guidance

Share on StockTwits

DENTSPLY SIRONA (NASDAQ:XRAY) updated its FY 2018 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of $2.00 for the period, compared to the Thomson Reuters consensus estimate of $2.08. DENTSPLY SIRONA also updated its FY18 guidance to $2.00-2.15 EPS.

A number of equities analysts have weighed in on the stock. HC Wainwright set a $40.00 target price on shares of DENTSPLY SIRONA and gave the company a hold rating in a research note on Friday, August 31st. ValuEngine raised shares of DENTSPLY SIRONA from a strong sell rating to a sell rating in a research note on Wednesday, October 24th. Robert W. Baird downgraded shares of DENTSPLY SIRONA from an outperform rating to a neutral rating and decreased their target price for the company from $56.00 to $38.00 in a research note on Tuesday, August 7th. Stifel Nicolaus reduced their price target on shares of DENTSPLY SIRONA from $57.00 to $46.00 and set a buy rating for the company in a research report on Wednesday, August 8th. Finally, Morgan Stanley downgraded shares of DENTSPLY SIRONA from an overweight rating to an equal weight rating and reduced their price target for the company from $54.00 to $40.00 in a research report on Wednesday, August 8th. Three analysts have rated the stock with a sell rating, eight have assigned a hold rating and six have assigned a buy rating to the company. The company presently has an average rating of Hold and a consensus price target of $51.50.

Shares of XRAY traded down $0.74 on Friday, hitting $36.06. 8,501,655 shares of the stock traded hands, compared to its average volume of 2,934,481. The company has a market capitalization of $8.12 billion, a P/E ratio of 14.21, a price-to-earnings-growth ratio of 2.12 and a beta of 1.15. The company has a quick ratio of 1.10, a current ratio of 1.69 and a debt-to-equity ratio of 0.31. DENTSPLY SIRONA has a one year low of $33.93 and a one year high of $68.98.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings results on Thursday, November 8th. The medical instruments supplier reported $0.38 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.46 by ($0.08). The firm had revenue of $928.40 million for the quarter, compared to the consensus estimate of $951.58 million. DENTSPLY SIRONA had a negative net margin of 39.62% and a positive return on equity of 9.12%. DENTSPLY SIRONA’s revenue was down 8.0% on a year-over-year basis. During the same period last year, the business earned $0.70 EPS. On average, sell-side analysts expect that DENTSPLY SIRONA will post 2.07 EPS for the current year.

TRADEMARK VIOLATION NOTICE: This piece of content was published by Week Herald and is owned by of Week Herald. If you are reading this piece of content on another site, it was stolen and reposted in violation of U.S. & international trademark & copyright legislation. The legal version of this piece of content can be viewed at


DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

See Also: Dollar Cost Averaging

Earnings History and Estimates for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with's FREE daily email newsletter.

Leave a Reply